Keck School Faculty

Richard Nisan Fine, MD
Richard Nisan Fine, MD
Clinical Professor of Pediatrics (Part-Time)
Pediatrics
IRD 105 2020 Zonal Avenue Off Campus Los Angeles

Kidney retransplantation in children following rejection and recurrent disease Pediatr Nephrol. 2016 Dec; 31(12):2235-2247. . View in PubMed

Kidney retransplantation in children following rejection and recurrent disease Pediatr Nephrol. 2016 12; 31(12):2235-2247. . View in PubMed

Tolerance in Solid-Organ Transplant Exp Clin Transplant. 2016 11; 14(Suppl 3):1-5. . View in PubMed

Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children Pediatr Nephrol. 2014 Aug; 29(8):1337-47. . View in PubMed

Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience Pediatr Transplant. 2014 Jun; 18(4):363-8. . View in PubMed

Growth following solid organ transplantation in childhood Clinics (Sao Paulo). 2014; 69 Suppl 1:3-7. . View in PubMed

Growth hormone treatment after renal transplantation: a promising but underused chance to improve growth Pediatr Nephrol. 2013 Jan; 28(1):1-4. . View in PubMed

A paradigm shift and a few modest suggestions in the care of adolescent transplant recipients Transplantation. 2011 Dec 15; 92(11):1191-3. . View in PubMed

Etiology and treatment of growth retardation in children with chronic kidney disease and end-stage renal disease: a historical perspective Pediatr Nephrol. 2010 Apr; 25(4):725-32. . View in PubMed

What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children, and adolescents with end-stage renal disease? Pediatr Nephrol. 2010 Apr; 25(4):739-46.. View in PubMed

Live unrelated donor renal transplantation in children--criteria of acceptability Pediatr Nephrol. 2009 Jul; 24(7):1425; author reply 1427. . View in PubMed

Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS Pediatr Transplant. 2008 Sep; 12(6):689-95. . View in PubMed

Current state of pediatric renal transplantation Front Biosci. 2008 Jan 01; 13:197-203. . View in PubMed

Management of growth retardation in pediatric recipients of renal allografts Nat Clin Pract Nephrol. 2007 Jun; 3(6):318-24. . View in PubMed

Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children Pediatr Nephrol. 2007 Apr; 22(4):496-502. . View in PubMed

Report of an NIH task force on research priorities in chronic kidney disease in children Pediatr Nephrol. 2006 Jan; 21(1):14-25. . View in PubMed

Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry Pediatr Nephrol. 2005 Mar; 20(3):404-8. . View in PubMed

Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS Pediatr Nephrol. 2003 Aug; 18(8):796-804. . View in PubMed

Tacrolimus vscyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study. Pediatr Transplant. 2003 Jun; 7(3):217-22. . View in PubMed

The role of APD in the management of pediatric patients: a report of the North American Pediatric Renal Transplant Cooperative Study Semin Dial. 2002 Nov-Dec; 15(6):427-9. . View in PubMed

Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS Kidney Int. 2002 Aug; 62(2):688-96. . View in PubMed

Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study Pediatrics. 2002 May; 109(5):909-13. . View in PubMed

Powered by SC CTSI
Go to Top